Results 211 to 220 of about 6,815,566 (351)

Simulation in support of software development [PDF]

, 1993
Darby F. McBeath, William S. Keezer
openalex   +1 more source

The dynamics of leadership and success in software development teams. [PDF]

Nat Commun
Betti L, Gallo L, Wachs J, Battiston F.
europepmc   +1 more source

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren, Moana Busch, Pedro A. Ruiz, Ermanno Malagola, Valeria Baumeler, Federica Foti, Adelina Gross, Tobias Grütter, Hendrik Edel, Cordelia Schuler, Kristina Handler, Glenn De Lange, Isabelle C. Arnold, Cheryl de Vallière, Klaus Seuwen, Martin Hausmann, Gerhard Rogler   +16 more
wiley   +1 more source

Agile Software Development [PDF]

, 2013
Meshcheryakov, L.I., Morozova, T.I., Seredinskaya, Olga   +2 more
core  

The European Space Software Development Environment Reference Facility Project [PDF]

, 1994
John Favaro, Yves Coene, Marco Casucci
openalex   +1 more source

AI-driven cybersecurity framework for software development based on the ANN-ISM paradigm. [PDF]

Sci Rep
Khan HU, Khan RA, Alwageed HS, Almagrabi AO, Ayouni S, Maddeh M.   +5 more
europepmc   +1 more source

Stakeholders' Perspectives on Partnering to Inform the Software Development Lifecycle of Smartphone Applications for People with Serious Mental Illness: Enhancing the Software Development Lifecycle Through Stakeholder Engagement. [PDF]

Proc IEEE Glob Humanit Technol Conf, 2021
Storm M, Venegas M, Gocinski A, Myers A, Brooks J, Fortuna KL.   +5 more
europepmc   +1 more source

TRPM8 levels determine tumor vulnerability to channel agonists

Molecular Oncology, EarlyView.
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo, Francesco Giuseppe Carbone, Kristi Buzo, Nicole Annesi, Sacha Genovesi, Annalisa Lorenzato, Karen Widmann, Michela Libergoli, Elisa Marmocchi, Giovanni Bertalot, Alberto Brolese, Mauro Giulio Papotti, Luca Molinaro, Orazio Caffo, Mattia Barbareschi, Alberto Bardelli, Alessandro Romanel, Sabrina Arena, Andrea Lunardi   +18 more
wiley   +1 more source

Promoting mental health in the workplace: web software development and validation. [PDF]

Rev Lat Am Enfermagem
Pinhatti EDG, Machado RCBR, Pimenta RA, Jaques AE, Haddad MDCFL.   +4 more
europepmc   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source